Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVietnam Ent Usd Regulatory News (VEID)

Share Price Information for Vietnam Ent Usd (VEID)

Share Price is delayed by 15 minutes
Get Live Data
10.50    0.00 (0.00%)
Bid:
10.00
Ask:
11.00
Spread: 1.00 (10.00%)
Market Cap: -
VEID Live PriceLast checked at - London Stock Exchange

Intraday Vietnam Ent Usd Share Chart

Directorate change

Today 07:25

RNS Number : 5458J
Vietnam Enterprise Investments Ltd
24 June 2026
Β 

Vietnam Enterprise Investments Limited

24 June 2026

Β 

Vietnam Enterprise Investments Limited

("VEIL" or the "Company")

Β 

VEIL is a London-listed investment company investing primarily in listed Vietnamese equities and is a FTSE 250 constituent.

Β 

Directorate Change

Appointment of Chair

Β 

The Board of the Company announces the appointment of Simon Davies as Independent Non-Executive Director and Chair of the Board with effect from 1 July 2026.Β Simon will succeed Charles Cade as Chair of the Board following a short handover period. Charles Cade, who has served as the Interim Chair since January 2026, will continue as the Company's Senior Independent Director. Simon willΒ sit on each of the Board committees, with the exception of the Audit and Risk Committee.

Β 

Simon is an internationally experienced Chair who has held senior roles across the legal, banking and sovereign sectors, with extensive experience of leading international teams in Asia and the Middle East.

Β 

SimonΒ is currently Chair of ICBC Standard Bank Plc. As Firmwide Managing Partner of Linklaters LLP from 2007 to 2015 he led the firm to record financial performance and grew the international network of the business in Africa, Australia, Asia, the Middle East and in the US, having earlier spent twelve years in Hong Kong and Tokyo culminating in the role of Asian Managing Partner. He went on to serve on the Executive Committee of Lloyds Banking Group plc, leading its People, Legal and Strategy functions, and, most recently, worked asΒ aΒ senior executive in the Middle East.

Β 

The appointment comes as the Board continues its programme to address the Company's discount to net asset value. Alongside an active share buyback programme, the Company completed a tender offer for up to 10 per cent of its share capital in January 2026 and announced a further tender offer for up to 10 per cent in June 2026, with the discount having narrowed materially over the period.

Β 

Simon's appointment is announced ahead of the Company's Annual General Meeting, to be held at Stationers' Hall, London at 12.00pm on Thursday,Β 25Β June 2026. Charles Cade as the Interim Chair will conduct the AGM as Simon's appointment will be in effect from 1Β July 2026. Simon will attend the AGM on 25Β June 2026 to give shareholders an early opportunity to meet with incoming Chair.

Β 

Simon Davies said: "It is a great privilege to be asked to chair VEIL, the largest and longest established investor in one of Asia's most dynamic economies. Vietnam's growth, reform agenda and capital market development make this an exciting time for the Company, and I look forward to working with the Board, the Investment Manager and shareholders to build on the progress already made and to continue the focus on delivering value for shareholders."

Β 

Charles Cade said: "On behalf of the Board, I am delighted to welcome Simon to VEIL. His international leadership experience, his understanding of Asia and emerging markets, and his expertise in governance and stakeholder engagement make him well suited to lead the Company through its next phase. The Board's work to narrow the discount and strengthen demand for the Company's shares will continue, and I look forward to supporting Simon as Senior Independent Director."

Β 

For further information, please contact:

Β 

Vietnam Enterprise Investments Limited

Steven Mantle

+44 (0)75537 01237

stevenmantle@dragoncapital.com

Β 

Jefferies International Limited

Stuart Klein

+44 (0)20 7029 8703

stuart.klein@jefferies.com

Β 

Montfort Communications

Alex Everett

+44 (0)77804 31533

Nita Shah

+44 (0)79041 20960

veil@montfort.london

Β 

h2Radnor

Iain Daly

+44 (0)20 3897 1830

idaly@h2radnor.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAGLGDLSDDDGLS
Date   Source Headline
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSNet Asset Value(s)
10th Feb 20267:00 amRNSNet Asset Value(s)
9th Feb 20267:00 amRNSDiscount Management Update - Replacement
9th Feb 20267:00 amRNSNet Asset Value(s)
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:06 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSNet Asset Value(s)
6th Feb 20267:00 amRNSDiscount Management Update
5th Feb 20267:00 amRNSNet Asset Value(s)
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSNet Asset Value(s)
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:48 amRNSNet Asset Value(s)
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSNet Asset Value(s)
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSNet Asset Value(s)
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSNet Asset Value(s)
28th Jan 20267:00 amRNSNet Asset Value(s)
27th Jan 20267:00 amRNSNet Asset Value(s)
26th Jan 20267:00 amRNSNet Asset Value(s)
23rd Jan 20267:00 amRNSNet Asset Value(s)
22nd Jan 202610:58 amRNSTotal Voting Rights (Replacement)
22nd Jan 20267:00 amRNSNet Asset Value(s)
21st Jan 20261:46 pmRNSRepurchase of Exit Shares - Total Voting Rights
21st Jan 20267:00 amRNSNet Asset Value(s)
21st Jan 20267:00 amRNSDirectorate change
20th Jan 20268:27 amRNSNet Asset Value(s)
19th Jan 20267:00 amRNSTender Pool Allocation and Tender Price
19th Jan 20267:00 amRNSNet Asset Value(s)
16th Jan 20263:26 pmRNSResult of Tender Offer
16th Jan 20267:00 amRNSNet Asset Value(s)
15th Jan 20267:00 amRNSNet Asset Value(s)
14th Jan 20267:00 amRNSNet Asset Value(s)
13th Jan 20267:00 amRNSNet Asset Value(s)
12th Jan 20267:00 amRNSNet Asset Value(s)
9th Jan 20267:00 amRNSNet Asset Value(s)
8th Jan 202611:47 amRNSResult of General Meeting
8th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSDiscount Management Update
6th Jan 20267:00 amRNSNet Asset Value(s)
5th Jan 20267:00 amRNSNet Asset Value(s)
31st Dec 20257:00 amRNSNet Asset Value(s)
30th Dec 20257:00 amRNSNet Asset Value(s)
29th Dec 20257:00 amRNSNet Asset Value(s)
29th Dec 20257:00 amRNSNet Asset Value(s)
24th Dec 20257:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.